Enhancing patient‐specific quality assurance for VMAT for breast cancer treatment: A machine learning approach for gamma passing rate (GPR) prediction
Journal of Applied Clinical Medical Physics · 2025-09 · 26 (9)
DOI: 10.1002/acm2.70251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, online erschienen am 08.09.2025. Verfasst von Francis C Djoumessi Zamo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre Clinical Soyaux, Centre de Radiothérapie Angouleme, Saint Michel, France. Hauptthemen laut MEDLINE: Machine Learning, Breast Neoplasms, Radiotherapy, Intensity-Modulated, Radiotherapy Planning, Computer-Assisted. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abdus Salam International Centre for Theoretical Physics.
Abstract (Originalsprache)
Background
Modern radiation therapy for breast cancer has significantly advanced with the adoption of volumetric modulated arc therapy (VMAT), offering enhanced precision and improved treatment efficiency.
Purpose
To ensure the accuracy and precision of such complex treatments, a robust patient‐specific quality assurance (PSQA) protocol is essential. This study investigates the potential of machine learning (ML) models to predict gamma passing rates (GPR), a key metric in PSQA.
Methods
A dataset comprising 863 VMAT plans was used to develop and compare seven ML models: Histogram‐based gradient boosting regressor, random forest regressor, extra trees regressor, gradient boosting regressor, linear regression, AdaBoost regressor, and Multi‐layer perceptron regressor. These models incorporated anatomical, dosimetric, and plan complexity features.
Results
Among the evaluated models, the extra trees regressor (ETR), random forest regressor (RFR), and gradient boosting regressor (GBR) demonstrated the best performance, achieving mean absolute errors (MAEs) of 0.51%, 0.52%, and 0.51%, and mean squared errors (MSEs) of 0.0051%, 0.0051%, and 0.0052%, respectively, on the validation dataset.
Conclusions
This study highlights the promise of ML‐based approaches in streamlining PSQA processes, thereby supporting the quality assurance of breast cancer treatments using VMAT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre Clinical Soyaux, Centre de Radiothérapie Angouleme, Saint Michel, France.
- Centre de Physique Atomique Moléculaire et Optique, University of DOUALA, Douala, Cameroun.
- Radiation Oncology Department, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
ORCID-Profile: Francis C Djoumessi Zamo
Förderung
- Abdus Salam International Centre for Theoretical Physics
Zitieren
APA
Zamo, F. C. D., Colliaux, A., Blot-Lafond, V., Moyo, N., & Njeh, C. F. (2025). Enhancing patient‐specific quality assurance for VMAT for breast cancer treatment: A machine learning approach for gamma passing rate (GPR) prediction. Journal of Applied Clinical Medical Physics, 26(9). https://doi.org/10.1002/acm2.70251
Vancouver
Zamo FCD, Colliaux A, Blot-Lafond V, Moyo N, Njeh CF. Enhancing patient‐specific quality assurance for VMAT for breast cancer treatment: A machine learning approach for gamma passing rate (GPR) prediction. Journal of Applied Clinical Medical Physics. 2025;26(9). doi:10.1002/acm2.70251
BibTeX
@article{Zamo2025,
author = {Zamo, Francis C Djoumessi and Colliaux, Anthony and Blot-Lafond, Valérie and Moyo, Ndontchueng and Njeh, Christopher F},
title = {Enhancing patient‐specific quality assurance for VMAT for breast cancer treatment: A machine learning approach for gamma passing rate (GPR) prediction},
journal = {Journal of Applied Clinical Medical Physics},
year = {2025},
volume = {26},
number = {9},
doi = {10.1002/acm2.70251}
}
EUVIMED